Company Analysis Bayer Aktiengesellschaft
1. Summary
Advantages
- Price (5.13 $) is less than fair price (7.46 $)
- The stock's return over the last year (-33.86%) is higher than the sector average (-34.04%).
Disadvantages
- Dividends (0.4107%) are below the sector average (1.76%).
- Current debt level 35.54% has increased over 5 years from 30.04%.
- The company's current efficiency (ROE=-8.93%) is lower than the sector average (ROE=13.19%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
20 november 02:13 Bayer plans to shift focus away from womenβs health drug research
2.3. Market efficiency
Bayer Aktiengesellschaft | Healthcare | Index | |
---|---|---|---|
7 days | 1.1% | 4.6% | -0.4% |
90 days | -22.2% | -37.6% | 1.5% |
1 year | -33.9% | -34% | 21.8% |
BAYRY vs Sector: Bayer Aktiengesellschaft has outperformed the "Healthcare" sector by 0.1858% over the past year.
BAYRY vs Market: Bayer Aktiengesellschaft has significantly underperformed the market by -55.63% over the past year.
Stable price: BAYRY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BAYRY with weekly volatility of -0.6511% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (5.13 $) is lower than the fair price (7.46 $).
Price significantly below the fair price: The current price (5.13 $) is 45.4% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (11.48) is lower than that of the sector as a whole (31.48).
P/E vs Market: The company's P/E (11.48) is lower than that of the market as a whole (46.91).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.2411) is lower than that of the sector as a whole (3.36).
P/BV vs Market: The company's P/BV (0.2411) is higher than that of the market as a whole (-8.98).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.1674) is lower than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (0.1674) is lower than that of the market as a whole (4.88).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (3.8) is lower than that of the sector as a whole (9.95).
EV/Ebitda vs Market: The company's EV/Ebitda (3.8) is lower than that of the market as a whole (25.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -16.22% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-16.22%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.93%).
5.4. ROE
ROE vs Sector: The company's ROE (-8.93%) is lower than that of the sector as a whole (13.19%).
ROE vs Market: The company's ROE (-8.93%) is lower than that of the market as a whole (-8.22%).
5.5. ROA
ROA vs Sector: The company's ROA (-2.38%) is lower than that of the sector as a whole (6.14%).
ROA vs Market: The company's ROA (-2.38%) is lower than that of the market as a whole (4.85%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.4107% is below the average for the sector '1.76%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.4107% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 0.4107% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (47.83%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription